Aaron Rosenberg
Chief Financial Officer · BeOne Medicines Ltd.
- 2025
- Aug 5, 2026
- 4
Summary
Latest filing:
Aaron Rosenberg is Chief Financial Officer of BeOne Medicines Ltd. (ONC). 4 SEC Form 4 filings on record going back to 2025, most recently on 5 August 2026. Most recent open-market trade: sold $362K of ONC on 5 August 2026. Lifetime open-market sales: $870K.
Recent transactions
6The latest 6 SEC Form 4 transactions reported by Aaron Rosenberg.
Trading pattern
InsiderAlpha's records for Aaron Rosenberg go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Aaron Rosenberg files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John Oyler - $189.61M in ONC purchases and sales in the last 12 months
- Xiaodong Wang - $24.68M in ONC purchases and sales in the last 12 months
- Xiaobin Wu - $8.75M in ONC purchases and sales in the last 12 months
- Chan Henry Lee - $4.20M in ONC purchases and sales in the last 12 months
- Lai Wang - $1.17M in ONC purchases and sales in the last 12 months
- Corazon (Corsee) D. Sanders - $961K in ONC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Aaron Rosenberg?
Aaron Rosenberg is a corporate insider, tracked as Chief Financial Officer of BeOne Medicines Ltd. (ONC). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Aaron Rosenberg submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Aaron Rosenberg been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($870K) across all tracked filings.